Phaseline

Targets › MG

MG: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Respiratory.

Open in Phaseline: the race on MG, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Zagazig UniversityMagnesium
Oral magnesium supplementation; mechanism in asthma likely involves smooth muscle relaxati
MGPhase 2Bronchial Asthma–

Conditions

Bronchial Asthma (1)

Modalities

small molecule (1)

Companies

Zagazig University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.